Giuliani, Virginia http://orcid.org/0000-0002-2439-4986
Miller, Meredith A.
Liu, Chiu-Yi
Hartono, Stella R. http://orcid.org/0000-0001-6234-3445
Class, Caleb A. http://orcid.org/0000-0003-3130-3613
Bristow, Christopher A.
Suzuki, Erika
Sanz, Lionel A.
Gao, Guang
Gay, Jason P.
Feng, Ningping
Rose, Johnathon L.
Tomihara, Hideo
Daniele, Joseph R.
Peoples, Michael D.
Bardenhagen, Jennifer P.
Geck Do, Mary K.
Chang, Qing E.
Vangamudi, Bhavatarini
Vellano, Christopher
Ying, Haoqiang http://orcid.org/0000-0003-0616-2310
Deem, Angela K.
Do, Kim-Anh
Genovese, Giannicola
Marszalek, Joseph R.
Kovacs, Jeffrey J.
Kim, Michael
Fleming, Jason B.
Guccione, Ernesto
Viale, Andrea
Maitra, Anirban http://orcid.org/0000-0001-7923-9978
Emilia Di Francesco, M.
Yap, Timothy A. http://orcid.org/0000-0002-2154-3309
Jones, Philip http://orcid.org/0000-0001-6149-8293
Draetta, Giulio http://orcid.org/0000-0001-5225-9610
Carugo, Alessandro http://orcid.org/0000-0001-5182-3320
Chedin, Frederic http://orcid.org/0000-0002-1306-5335
Heffernan, Timothy P. http://orcid.org/0000-0002-3166-8922
Article History
Received: 13 February 2020
Accepted: 5 July 2021
First Online: 30 July 2021
Competing interests
: G. F. D. reports personal fees from and stock ownership in Karyopharm Therapeutics, Forma Therapeutics, Metabomed, BiovelocITA, Nurix and Orionis Biosciences; and personal fees from Blueprint Medicines, Taiho Pharmaceutical, Symphogen and Helsinn Ventures. T. P. H. reports personal fees and stock ownership from Cullgen Inc. The remaining authors declare no competing interests.